Ligand validation:8AQ3

6OU: [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate

6OU is a Ligand Of Interest in 8AQ3 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8AQ3_6OU_A_601	39%	50%	0.222	0.928	1.02	0.9	4	2	6	0	100%	1
8AQ3_6OU_A_620	4%	51%	0.288	0.669	1.02	0.87	4	2	0	0	100%	1
8AQ3_6OU_A_602	1%	51%	0.421	0.53	1.02	0.88	4	2	1	0	100%	1
8AQ4_6OU_A_608	12%	46%	0.323	0.922	1.1	0.99	2	1	6	0	65%	0.6531
6BR8_6OU_A_401	46%	49%	0.157	0.892	0.89	1.09	4	2	0	0	100%	0.9592
6BR9_6OU_A_405	38%	50%	0.185	0.886	0.93	1.01	3	4	2	0	100%	0.7551
6N4I_6OU_A_1001	24%	34%	0.189	0.912	1.57	1.04	4	2	1	0	49%	0.4898
8GYN_6OU_A_201	17%	35%	0.233	0.813	1.33	1.24	3	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.